Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to "Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years" [Vaccine 40 (2022) 4190-4198].
Chichili GR, Smulders R, Santos V, Cywin B, Kovanda L, Van Sant C, Malinoski F, Sebastian S, Siber G, Malley R. Chichili GR, et al. Among authors: smulders r. Vaccine. 2024 Oct 3;42(23):126023. doi: 10.1016/j.vaccine.2024.05.071. Epub 2024 Jun 18. Vaccine. 2024. PMID: 38897894 Free article. No abstract available.
Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy.
Calise J, DeBerg H, Garabatos N, Khosa S, Bajzik V, Calderon LB, Aldridge K, Rosasco M, Ferslew BC, Zhu T, Smulders R, Wheatley LM, Laidlaw TM, Qin T, Chichili GR, Adelman DC, Farrington M, Robinson D, Jeong D, Jones SM, Sanda S, Larson D, Kwok WW, Baloh C, Nepom GT, Wambre E; IMPACT. Calise J, et al. Among authors: smulders r. J Allergy Clin Immunol. 2023 Jul;152(1):155-166.e9. doi: 10.1016/j.jaci.2023.03.020. Epub 2023 Mar 30. J Allergy Clin Immunol. 2023. PMID: 37003475 Free PMC article.
Safety, reactogenicity, and immunogenicity of a novel 24-valent pneumococcal vaccine candidate in healthy, pneumococcal vaccine-naïve Japanese adults: A phase 1 randomized dose-escalation trial.
Borys D, Smulders R, Haranaka M, Nakano T, Chichili GR, Ebara M, Hashimoto A, Iwahana M, Oizumi Y, Nanra J, Malley R, Sebastian S. Borys D, et al. Among authors: smulders r. Vaccine. 2025 Jan 12;44:126545. doi: 10.1016/j.vaccine.2024.126545. Epub 2024 Nov 29. Vaccine. 2025. PMID: 39612802 Free article. Clinical Trial.
Pulsed processing by cold plasma, applied to industrial emission control.
Van Heesch EJM, Huiskamp T, Yan K, Beckers FJCM, Smulders HWM, Winands GJJ, Lemmens RHP, Blom PPM, Segura SD, Hoeben WFLM, Van Paasen SVB, Van Oorschot JJ, Bonkestoter AGA, Van Den Brand MLJ, Hennink M, Smulders RWJ, Pemen AJM, Van Der Laan PCT. Van Heesch EJM, et al. Among authors: smulders rwj. Front Chem. 2024 Jun 7;12:1386055. doi: 10.3389/fchem.2024.1386055. eCollection 2024. Front Chem. 2024. PMID: 38911992 Free PMC article.
Single- and multiple-dose safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of ASP0367, or bocidelpar sulfate, a novel modulator of peroxisome proliferator-activated receptor delta in healthy adults: Results from a phase 1 study.
Ito M, Tauscher-Wisniewski S, Smulders RA, Wojtkowski T, Yamada A, Koibuchi A, Uz T, Marek GJ, Goldwater RD. Ito M, et al. Among authors: smulders ra. Muscle Nerve. 2022 Jan;65(1):110-120. doi: 10.1002/mus.27436. Epub 2021 Oct 28. Muscle Nerve. 2022. PMID: 34642949 Free PMC article. Clinical Trial.
Implementation of the kidney team at home intervention: Evaluating generalizability, implementation process, and effects.
Redeker S, Massey EK, Boonstra C, van Busschbach JJ, Timman R, Brulez HFH, Hollander DAAMJ, Hilbrands LB, Bemelman F, Berger SP, van de Wetering J, van den Dorpel RMA, Dekker-Jansen M, Weimar W, Ismail SY; Kidney Team at Home consortium. Redeker S, et al. Transpl Int. 2021 Nov;34(11):2317-2328. doi: 10.1111/tri.14011. Epub 2021 Sep 21. Transpl Int. 2021. PMID: 34390041 Free PMC article.
ASP5094, a humanized monoclonal antibody against integrin alpha-9, did not show efficacy in patients with rheumatoid arthritis refractory to methotrexate: results from a phase 2a, randomized, double-blind, placebo-controlled trial.
Takeuchi T, Tanaka Y, Erdman J, Kaneko Y, Saito M, Higashitani C, Smulders R, Lademacher C. Takeuchi T, et al. Among authors: smulders r. Arthritis Res Ther. 2020 Oct 21;22(1):252. doi: 10.1186/s13075-020-02336-3. Arthritis Res Ther. 2020. PMID: 33087159 Free PMC article. Clinical Trial.
53 results